Back

Real world experience of efficacy and safety using proprotein convertase subtilisin / Kexin 9 (PCSK9) inhibition in patients with Familial Hypercholesterolemia

6 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session III - Saturday 08:30 - 12:30 - Diabetes/ Lipids/Obesity/Nutrition_Part 1 Lipids EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Doctor Annette Galema-Boers

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

14 More presentations in this session

Presentation thumbnail
Diabetes/ Lipids/Obesity/Nutrition_Part 1 - Poster discussant:
Presentation thumbnail
ISR treatment with DCB for prevention of recurrent restenosis in diabetic patients: a two centers experience.
Presentation thumbnail
Dynamics of parameters of endothelial function in patients with type 2 diabetes according to flow-mediated dilation during the CPAP-therapy
Associate Professor N. Burko (Penza, RU)
Abstract
Presentation thumbnail
Investigation of the association of CRP with the 10-year (2002-2012) diabetes incidence; the mediating role of central obesity.
Professor D. Panagiotakos (Athens, GR)
Abstract
Presentation thumbnail
Diabetes/ Lipids/Obesity/Nutrition_Part 1 - Poster discussant:.

Access the full session

Session thumbnail
Poster Session III - Saturday 08:30 - 12:30 - Diabetes/ Lipids/Obesity/Nutrition_Part 1

The Event

Event poster

EuroPrevent 2017

6 April - 8 April 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources